Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4114806
Max Phase: Preclinical
Molecular Formula: C21H21NO7
Molecular Weight: 399.40
Molecule Type: Small molecule
Associated Items:
ID: ALA4114806
Max Phase: Preclinical
Molecular Formula: C21H21NO7
Molecular Weight: 399.40
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)OC/C=C/CC1(C(=O)OCc2ccccc2)/C(=C/C=O)O[C@@H]2CC(=O)N21
Standard InChI: InChI=1S/C21H21NO7/c1-15(24)27-12-6-5-10-21(20(26)28-14-16-7-3-2-4-8-16)17(9-11-23)29-19-13-18(25)22(19)21/h2-9,11,19H,10,12-14H2,1H3/b6-5+,17-9-/t19-,21?/m1/s1
Standard InChI Key: BGQRDDSRQMAZIR-VOXXZNBISA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 399.40 | Molecular Weight (Monoisotopic): 399.1318 | AlogP: 1.65 | #Rotatable Bonds: 8 |
Polar Surface Area: 99.21 | Molecular Species: NEUTRAL | HBA: 7 | HBD: 0 |
#RO5 Violations: 0 | HBA (Lipinski): 8 | HBD (Lipinski): 0 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: | CX LogP: 1.15 | CX LogD: 1.15 |
Aromatic Rings: 1 | Heavy Atoms: 29 | QED Weighted: 0.22 | Np Likeness Score: 1.10 |
1. (2015) Substituted clavulanic acid, |
Source(1):